Home / CANCER BUZZ Podcast

CANCER BUZZ Podcast

Want the latest BUZZ? Just listen in!

The CANCER BUZZ podcast features fresh perspectives on hot topics in oncology care delivery. CANCER BUZZ is where stakeholders from the front lines of care to the C-suite, from research to the registry, from chairside to benchside, talk about top-of-mind questions and real-world impact.

Listen to the CANCER BUZZ podcast on Apple PodcastsSpotify, Amazon Music, or wherever you get your podcasts. You can now listen with your smart home device. For instructions on how to listen with Alexa, click here, or just tell Alexa to "Play CANCER BUZZ." For Google Home instructions, click here.

Filter By Podcast Format

 
 
 
Working under the hypothesis that a subset of de novo oligometastatic breast cancer patients who are treated with a combination of systemic therapy, surgery, and radiation or ablation of metastatic sites will have long-term distant metastasis free and overall survival, this multi-cohort, prospective, nationwide registry study will enroll newly diagnosed oligometastatic HER2+ breast cancer …
As biomarker testing can play a critical role in the diagnosis of rare cancers, such as NTRK gene fusion-positive cancers, hear what care teams need to know about identifying patients who may be eligible for this testing.
Breaking down the social stigma that is often still associated with seeking mental health services is key to making cancer care clinicians and staff feel a "sense of safety" and that they will not be penalized for accessing mental health services.
In 2022, ACCC conducted a survey to measure patient, caregiver, and provider perceptions and adoption of messaging tools, electronic questionnaires, and connected devices used to track and monitor symptoms during cancer treatment.
As myeloproliferative neoplasms (MPNs) carry a heavy symptom burden which can significantly impact a patient’s quality of life, hear how multidisciplinary care and psycho-social support can help alleviate this burden for patients.
The goal of treatment for most patients with myelofibrosis is to relieve symptoms. Hear Dr. Gerds discuss standard of care treatment options and new therapies for treating patients with myelofibrosis.
Each year, ACCC is active at the state and federal level, advocating on behalf of its members. In this episode, learn what four core areas ACCC members identified as needing added support.
Tune-in as Dr. Hobbs discusses symptom scoring, risk stratification, and effective practices in building a strong myelofibrosis program.
Listen as Cindy Varga, MD, discusses the positives and negatives with subcutaneous versus intravenous drugs in treating patients with multiple myeloma.
Learn more about a care delivery model that can identify, implement, and expedite patient lung nodule care in real time and provide consistent follow-up along the continuum of care.
Learn how recent guideline and treatment options by the National Comprehensive Cancer Network (NCCN) can optimize care for patients with MPNs.
Hear suggestions for how to reduce financial hurdles and increase access to cancer diagnostics.
As cancer programs seek new ways to improve coordination of molecular testing, hear how precision medicine stewards can streamline testing processes to improve efficiency and improve the patient experience.
As myeloproliferative neoplasms (MPNs) carry a significant symptom burden and oftentimes can require lifelong care coordination and close monitoring, hear how a strong multidisciplinary approach can impact shared decision-making and patient engagement.
Over half of patients newly diagnosed with multiple myeloma are not eligible for transplant due to age or other major health problems. Listen as Dr. Yee provides treatment planning options available to patients who are ineligible for transplant.
Hear the most up-to-date best practices, including shared decision-making, regarding treating patients with CLL in this post-COVID era.
As community care teams work to provide equitable care for patients with chronic lymphocytic leukemia (CLL), understanding disparities as well as state and region-specific barriers that impact care is critical.
Andre Harvin teases his keynote at the ACCC 49th Annual Meeting and Cancer Center Business Summit, where he will talk about innovative solutions to streamline pharmacy operations that have saved his healthcare system millions of dollars. One of those innovative solutions—robotic pharmacists.
Kevin Davies, PhD, author of Editing Humanity: The CRISPR Revolution and the New Era of Genome Editing, teases his keynote at the ACCC 49th Annual Meeting and Cancer Center Business Summit, where he will talk about the history of genome technology and its potential to change precision medicine.
CANCER BUZZ speaks with Srdan Verstovsek, MD, PhD, about when to begin therapeutic care for myeloproliferative neoplasms (MPNs) and the urgency of treatment.
The views and opinions expressed herein are those of the author(s)/faculty member(s) and do not reflect the official policy or position of their employer(s) or the Association of Community Cancer Centers.